We have developed a standard practice to perform toxicological risk assessments of exogenous ingredients used in cannabinoid formulations for vaporization devices to reject or accept with calculated acceptable use limits based on the available scientific literature and new approach methodologies. Using this practice, this study aims to evaluate the potential risks these additives pose to users and identify harmful compounds that are currently present in vaporizer products on the market. Through quantitative GC/MS analysis of a targeted list of compounds in products from multiple terpene manufacturers, this study detected various toxic additives that could compromise consumer health.

This session will review the safety assessment framework adopted as a global standard by ASTM. It will highlight specific higher-risk ingredients and identify how prevalent they are in vaporization products currently in the cannabis market. The findings highlight an urgent need for a toxicological review of non-cannabinoid additives used in inhalable products to reduce potential health risks. By implementing rigorous safety standards, the cannabis industry can reduce the risk to consumer health, prevent over-regulation and flavor bans, and support the longevity of the industry.

Learning Objectives:

• Learn about the ASTM newly adopted risk assessment standard for cannabis vaporizer additives
  

• Gain insights into specific compounds found in vape additives that pose potential toxicological risks